Regeneron Team IDs Potential Target for Rare Bone Disease

Thursday, September 3, 2015

Source: FierceBiotechIT

A fast-growing Regeneron ($REGN) says a team of top researchers has identified a clear target for a rare genetic bone disease. And they have an antibody in preclinical testing that could correct the disorder.

View All News »